Abstract
I n an era of increasing resource consciousness on the part of healthcare authorities, 1 the answer is a resounding ‘Yes’. While pharmacoeconomic evaluation is still an evolving science, the economic data produced are becoming increasingly relevant for all players in the healthcare arena. The growing need for such evaluations was a major topic of discussion at a recent IIR conference entitled ‘Cost-effective economic evaluations’ [London, UK; November 1994].
Additional information
1. Wells N. Economic evaluation of drugs. A UK pharmaceutical industry perspective. PharmacoEconomics 1: 14-19, Jan 1992
Rights and permissions
About this article
Cite this article
Wells, N. Is there a need for pharmacoeconomic evaluation?. Pharmacoecon. Outcomes News 18, 3–4 (1994). https://doi.org/10.1007/BF03289951
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03289951